The order of authors' affiliations in the published version of this article was not consistent with the order in the submitted manuscript due to typesetting.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s12026-020-09134-8 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Correction to: The immune regulatory function of B7-H3 in malignancy: spotlight on the IFN-STAT1 axis and regulation of tumor-associated macrophages.
Immunol Res
August 2024
Department of Rheumatology, College of Medicine, Korea University, Seoul, South Korea.
Correction: Mifepristone inhibited the expression of B7-H2, B7-H3, B7-H4 and PD-L2 in adenomyosis.
Reprod Biol Endocrinol
October 2023
Department of Obstetrics and Gynaecology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, 250021, People's Republic of China.
Correction: B7-H3 expression is associated with high PD-L1 expression in clear cell renal cell carcinoma and predicts poor prognosis.
Diagn Pathol
May 2023
Department of Pathology, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Korea.
Erratum: Expression of B7-H3 Correlates with PD-L1 and Poor Prognosis in Patients with Cervical Cancer [Corrigendum].
Onco Targets Ther
November 2021
[This corrects the article DOI: 10.2147/OTT.S318082.
View Article and Find Full Text PDFCorrection to: B7-H3 promotes aggression and invasion of hepatocellular carcinoma by targeting epithelial-to-mesenchymal transition via JAK2/STAT3/Slug signaling pathway.
Cancer Cell Int
October 2021
Department of Liver Diseases, Bethune International Peace Hospital, Shijiazhuang, Hebei, People's Republic of China.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!